Cipher Mining Announces Acquisition of 200 MW Site in Ohio

Cipher Mining Announces Acquisition of 200 MW Site in Ohio GlobeNewswire December 23, 2025 Site acquisition includes 195 acres of land in Ohio and all necessary interconnection approvals to participate in the PJM market Site is well-suited for HPC applications and expected to energize in 2027 NEW YORK, Dec. 23, 2025 (GLOBE NEWSWIRE) — Cipher […]

Diginex Provides Update on Acquisition Progress

(NASDAQ:DGNX),(Boerse Frankfurt – Freiverkehr:I0Q.F),(Tradegate:I0Q.F), LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), announced a strategic update on its forward-looking acquisition roadmap, underscoring the Company's commitment to accelerating growth, expanding market reach, and strengthening its competitive position in the rapidly evolving ESG and compliance landscape. Resulticks Update Diginex remains

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods(R) IBS Test

(NASDAQ:BMRA), CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure. The $300 rate will apply to claims approved and paid by Medicare with dates of service on or after January 1, 2026. Adults of Medicare age comprise over 20% of US adults

Diginex Provides Update on Acquisition Progress

Diginex Provides Update on Acquisition Progress GlobeNewswire December 23, 2025 LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) — Diginex Limited (NASDAQ: DGNX) (“Diginex” or the “Company”), announced a strategic update on its forward-looking acquisition roadmap, underscoring the Company's commitment to accelerating growth, expanding market reach, and strengthening its competitive position in the rapidly evolving ESG and

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods(R) IBS Test

Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods(R) IBS Test GlobeNewswire December 23, 2025 CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare expenditure. The $300 rate will apply to claims approved and paid by Medicare with dates of service

VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio

(NASDAQ:VVPR), Focus will be on key markets with a shortage of AI compute infrastructure and where VivoPower has entrenched relationships, including Southeast Asia, Saudi Arabia, the UAE, and select EU markets Given the surge in demand from AI hyperscalers for low-cost sustainable power, VivoPower is reviewing its legacy portfolio of up to 682MW solar development

LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for its State-of-the-Art Test Demonstration Facility located at the K-1330 building on the Historic K-25 Site

LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment reached critical regulatory milestone with Receipt of a State of Tennessee Radioactive Material License in Oak Ridge, Tennessee test demonstration facility. Oak Ridge, Tennessee, Dec. 23, 2025 (GLOBE NEWSWIRE) — LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced

VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio

VivoPower Announces Strategic Refocus on Power-To-X, With X Being Sovereign AI Compute Infrastructure; Initiates Review of Legacy 682MW Solar Power Development Portfolio GlobeNewswire December 23, 2025 Focus will be on key markets with a shortage of AI compute infrastructure and where VivoPower has entrenched relationships, including Southeast Asia, Saudi Arabia, the UAE, and select EU

LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for its State-of-the-Art Test Demonstration Facility located at the K-1330 building on the Historic K-25 Site

LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for its State-of-the-Art Test Demonstration Facility located at the K-1330 building on the Historic K-25 Site GlobeNewswire December 23, 2025 LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment reached critical regulatory milestone with

LIS Technologies Inc. Announces Critical Regulatory Milestone with Receipt of a State of Tennessee Radioactive Material License for Its State-of-the-Art Test Demonstration Facility Located at the K-1330 Building on the Historic K-25 Site

Oak Ridge, Tennessee–(Newsfile Corp. – December 23, 2025) – LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of advanced laser technology and the only USA-origin and patented laser uranium enrichment company, today announced that it has received a Radioactive Material License from the State of Tennessee for its state-of-the-art Test Demonstration Facility located

Scroll to Top